Von Willebrand factor (Recombinant) | m-entrepreneurship.com

Product Name :
Von Willebrand factor (Recombinant)

Search keywords :
von Willebrand Factor

drugId :
null

Target Vo:
Coagulation factor VIII

Target Vo Short Name :
F8

Moa_Name:
Coagulation factor VIII stimulants

First Approval Country :
United States

First Approval Date Filter:
2015

Origin Company_Name :
Baxalta Incorporated

Active Company_Name :
Baxalta Innovations Gmbh

Active Indication_Name:
von Willebrand Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Met (C-Met) Antibody
ADAR1 Antibody (YA1658)
CD4 Antibody: CD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to CD4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts